AdvisorShares Psychedelics ETF
Giá lên
Cập nhật

Value Investing: STOCKS to watch in 2024

329
Hi Traders, Investors and Speculators of Charts📈📉

Welcome to 2024🥂🥳

After great feedback from the altcoin list, I'll be doing a series on top stocks to watch for 2024, all in one post for your convenience!

Stocks I'll focus on include:
📢 Undervalued stocks
📢 Stocks with great upside potential
📢 New stocks to watch

I'll keep adding/updating one by one to the bottom of this post, so make sure you bookmark and follow!

1) PSIL
The AdvisorShares Psychedelics ETF (NYSE ticker: PSIL) invests in the emerging psychedelic drugs sector, offering exposure to those biotechnology, pharmaceutical and life sciences companies we see as leading the way in this nascent industry.
ảnh chụp nhanh
Ghi chú
2) MSOS
The fund is an actively managed ETF that invests, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the USA.
ảnh chụp nhanh
Ghi chú
3) HOOD / Robinhood
ảnh chụp nhanh
Ghi chú
4) AMZN / AMAZON
Although AMAZON has recently made new ATH's, a strong V-shaped recovery suggests that this stock is indeed very popular, and ready to be bought up by byers at lower prices. Amazon needs no introduction, and with expansions in other countries (South Africa expects AMZN to launch this year) I expect the market cap to increase even further. Although trading at high prices right now, it's definitely a solid stock to keep as part of a diversified portfolio.
ảnh chụp nhanh
Ghi chú
5) ATAI Life Sciences
ATAI Life Sciences NV is a Germany-based clinical-stage biopharmaceutical company. The Company engages in developing various treatments that focuses on various mental health disorders.
ảnh chụp nhanh
Ghi chú
6) COIN / Coinbase
A large cryptocurrency exchange stock with good upside potential:
ảnh chụp nhanh

Thông báo miễn trừ trách nhiệm

Thông tin và các ấn phẩm này không nhằm mục đích, và không cấu thành, lời khuyên hoặc khuyến nghị về tài chính, đầu tư, giao dịch hay các loại khác do TradingView cung cấp hoặc xác nhận. Đọc thêm tại Điều khoản Sử dụng.